Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: a multicentre study
View ORCID ProfileOlga Nigro, Graziella Pinotti, Federica De Galitiis, Francesca Romana Di Pietro, Raffaele Giusti, Marco Filetti, Melissa Bersanelli, Alessandro Lazzarin, Paola Bordi, Annamaria Catino, Pamela Pizzutilo, Domenico Galetta, Paolo Marchetti, Andrea Botticelli, Simone Scagnoli, Marco Russano, Daniele Santini, Mariangela Torniai, Rossana Berardi, Biagio Ricciuti, Andrea De Giglio, Rita Chiari, Alessandro Russo, Vincenzo Adamo, Marianna Tudini, Rosa Rita Silva, Elena Bolzacchini, Monica Giordano, Pietro Di Marino, Michele De Tursi, Erika Rijavec, Michele Ghidini, Ilaria Vallini, Luigia Stefania Stucci, Marco Tucci, Laura Pala, Fabio Conforti, Paola Queirolo, Enrica Tanda, Francesco Spagnolo, Federica Cecchi, Sergio Bracarda, Serena Macrini, Matteo Santoni, Nicola Battelli, Maria Concetta Fargnoli, Giampiero Porzio, Alessandro Tuzi, Matteo Basilio Suter, Corrado Ficorella, View ORCID ProfileAlessio Cortellini
doi: https://doi.org/10.1101/2020.04.09.20054031
Olga Nigro
1Medical Oncology, ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy
MDGraziella Pinotti
1Medical Oncology, ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy
MDFederica De Galitiis
2Oncologia ed Oncologia Dermatologica, IDI-IRCCS, Roma, Italy
MDFrancesca Romana Di Pietro
2Oncologia ed Oncologia Dermatologica, IDI-IRCCS, Roma, Italy
3Medical Oncology, Azienda Ospedaliero-Universitaria Sant’Andrea, Roma, Italy
MDRaffaele Giusti
3Medical Oncology, Azienda Ospedaliero-Universitaria Sant’Andrea, Roma, Italy
MDMarco Filetti
3Medical Oncology, Azienda Ospedaliero-Universitaria Sant’Andrea, Roma, Italy
MDMelissa Bersanelli
4Medical Oncology, Azienda Ospedaliero-Universitaria di Parma, Italy
MDAlessandro Lazzarin
4Medical Oncology, Azienda Ospedaliero-Universitaria di Parma, Italy
MDPaola Bordi
4Medical Oncology, Azienda Ospedaliero-Universitaria di Parma, Italy
MDAnnamaria Catino
5Thoracic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II”, Bari, Italy
MDPamela Pizzutilo
5Thoracic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II”, Bari, Italy
MDDomenico Galetta
5Thoracic Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II”, Bari, Italy
MDPaolo Marchetti
2Oncologia ed Oncologia Dermatologica, IDI-IRCCS, Roma, Italy
6Dipartimento di Scienze Medico-Chirurgiche e Medicina Traslazionale Università “La Sapienza” Roma
MDAndrea Botticelli
6Dipartimento di Scienze Medico-Chirurgiche e Medicina Traslazionale Università “La Sapienza” Roma
MD, PhDSimone Scagnoli
6Dipartimento di Scienze Medico-Chirurgiche e Medicina Traslazionale Università “La Sapienza” Roma
MDMarco Russano
7Medical Oncology, Campus Bio-Medico, Roma, Italy
MDDaniele Santini
7Medical Oncology, Campus Bio-Medico, Roma, Italy
MDMariangela Torniai
8Clinica Oncologica, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria Ospedali Riuniti Umberto I, GM Lancisi, G Salesi, Ancona, Italy
MDRossana Berardi
8Clinica Oncologica, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria Ospedali Riuniti Umberto I, GM Lancisi, G Salesi, Ancona, Italy
MDBiagio Ricciuti
9Department of Surgical and Biomedical Sciences, University of Perugia, Perugia, Italy
MDAndrea De Giglio
9Department of Surgical and Biomedical Sciences, University of Perugia, Perugia, Italy
MDRita Chiari
10Medical Oncology, Ospedali Riuniti Padova Sud “Madre Teresa Di Calcutta”, Monselice, Italy
MDAlessandro Russo
11Medical Oncology, A.O. Papardo & Department of Human Pathology, University of Messina, Italy
MD, PhDVincenzo Adamo
11Medical Oncology, A.O. Papardo & Department of Human Pathology, University of Messina, Italy
MDMarianna Tudini
12Medical Oncology, ASUR Marche, Area Vasta 2, Fabriano, Italy
MDRosa Rita Silva
12Medical Oncology, ASUR Marche, Area Vasta 2, Fabriano, Italy
MDElena Bolzacchini
13Medical Oncology, ASST Lariana, Ospedale Sant’Anna, Como, Italy
MDMonica Giordano
13Medical Oncology, ASST Lariana, Ospedale Sant’Anna, Como, Italy
MDPietro Di Marino
14Clinical Oncology Unit, S.S. Annunziata Hospital, Chieti, Italy
MDMichele De Tursi
15Department of Medical, Oral and Biotechnological Sciences, University G. D’Annunzio, Chieti-Pescara, Italy
MDErika Rijavec
16Medical Oncology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
MDMichele Ghidini
16Medical Oncology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
MD, PhDIlaria Vallini
1Medical Oncology, ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy
Luigia Stefania Stucci
17Medical Oncology Unit, University of Bari, Department of biomedical sciences and human oncology, Bari, Italy
MD, PhDMarco Tucci
17Medical Oncology Unit, University of Bari, Department of biomedical sciences and human oncology, Bari, Italy
25National Cancer Research Center, Tumori Institute Giovanni Paolo II, Bari, Italy
MD, PhDLaura Pala
18Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy
MDFabio Conforti
18Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy
MDPaola Queirolo
18Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy
MDEnrica Tanda
19IRCCS Ospedale Policlinico San Martino, Genova, Italy
MDFrancesco Spagnolo
19IRCCS Ospedale Policlinico San Martino, Genova, Italy
MDFederica Cecchi
19IRCCS Ospedale Policlinico San Martino, Genova, Italy
MDSergio Bracarda
20Department of Medical Oncology, “Santa Maria” Hospital, Terni, Italy
MDSerena Macrini
20Department of Medical Oncology, “Santa Maria” Hospital, Terni, Italy
MDMatteo Santoni
21Department of Oncology, Macerata Hospital, Macerata. Italy
MDNicola Battelli
21Department of Oncology, Macerata Hospital, Macerata. Italy
MDMaria Concetta Fargnoli
22Department of Dermatology, St. Salvatore Hospital, L’Aquila, Italy
23Department of Biotechnology and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy
MDGiampiero Porzio
22Department of Dermatology, St. Salvatore Hospital, L’Aquila, Italy
24Medical Oncology, St. Salvatore Hospital, L’Aquila, Italy
MDAlessandro Tuzi
1Medical Oncology, ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy
MDMatteo Basilio Suter
1Medical Oncology, ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy
MDCorrado Ficorella
22Department of Dermatology, St. Salvatore Hospital, L’Aquila, Italy
24Medical Oncology, St. Salvatore Hospital, L’Aquila, Italy
MDAlessio Cortellini
22Department of Dermatology, St. Salvatore Hospital, L’Aquila, Italy
24Medical Oncology, St. Salvatore Hospital, L’Aquila, Italy
MDData Availability
the datasets used during the present study are available from the corresponding author upon reasonable request
Posted April 14, 2020.
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: a multicentre study
Olga Nigro, Graziella Pinotti, Federica De Galitiis, Francesca Romana Di Pietro, Raffaele Giusti, Marco Filetti, Melissa Bersanelli, Alessandro Lazzarin, Paola Bordi, Annamaria Catino, Pamela Pizzutilo, Domenico Galetta, Paolo Marchetti, Andrea Botticelli, Simone Scagnoli, Marco Russano, Daniele Santini, Mariangela Torniai, Rossana Berardi, Biagio Ricciuti, Andrea De Giglio, Rita Chiari, Alessandro Russo, Vincenzo Adamo, Marianna Tudini, Rosa Rita Silva, Elena Bolzacchini, Monica Giordano, Pietro Di Marino, Michele De Tursi, Erika Rijavec, Michele Ghidini, Ilaria Vallini, Luigia Stefania Stucci, Marco Tucci, Laura Pala, Fabio Conforti, Paola Queirolo, Enrica Tanda, Francesco Spagnolo, Federica Cecchi, Sergio Bracarda, Serena Macrini, Matteo Santoni, Nicola Battelli, Maria Concetta Fargnoli, Giampiero Porzio, Alessandro Tuzi, Matteo Basilio Suter, Corrado Ficorella, Alessio Cortellini
medRxiv 2020.04.09.20054031; doi: https://doi.org/10.1101/2020.04.09.20054031
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: a multicentre study
Olga Nigro, Graziella Pinotti, Federica De Galitiis, Francesca Romana Di Pietro, Raffaele Giusti, Marco Filetti, Melissa Bersanelli, Alessandro Lazzarin, Paola Bordi, Annamaria Catino, Pamela Pizzutilo, Domenico Galetta, Paolo Marchetti, Andrea Botticelli, Simone Scagnoli, Marco Russano, Daniele Santini, Mariangela Torniai, Rossana Berardi, Biagio Ricciuti, Andrea De Giglio, Rita Chiari, Alessandro Russo, Vincenzo Adamo, Marianna Tudini, Rosa Rita Silva, Elena Bolzacchini, Monica Giordano, Pietro Di Marino, Michele De Tursi, Erika Rijavec, Michele Ghidini, Ilaria Vallini, Luigia Stefania Stucci, Marco Tucci, Laura Pala, Fabio Conforti, Paola Queirolo, Enrica Tanda, Francesco Spagnolo, Federica Cecchi, Sergio Bracarda, Serena Macrini, Matteo Santoni, Nicola Battelli, Maria Concetta Fargnoli, Giampiero Porzio, Alessandro Tuzi, Matteo Basilio Suter, Corrado Ficorella, Alessio Cortellini
medRxiv 2020.04.09.20054031; doi: https://doi.org/10.1101/2020.04.09.20054031
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2253)
- Dermatology (199)
- Emergency Medicine (368)
- Epidemiology (11542)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3539)
- Geriatric Medicine (336)
- Health Economics (611)
- Health Informatics (2283)
- Health Policy (909)
- Hematology (333)
- HIV/AIDS (741)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (385)
- Neurology (3322)
- Nursing (189)
- Nutrition (504)
- Oncology (1747)
- Ophthalmology (521)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (221)
- Palliative Medicine (66)
- Pathology (434)
- Pediatrics (997)
- Primary Care Research (398)
- Public and Global Health (5966)
- Radiology and Imaging (1213)
- Respiratory Medicine (806)
- Rheumatology (367)
- Sports Medicine (309)
- Surgery (383)
- Toxicology (50)
- Transplantation (169)
- Urology (142)